The Global Influenza Market is expected to reach USD 9.33 billion by 2021 from USD 5.97 billion in 2016, growing at a CAGR of 8.54% during the forecast period, 2016-2021.

View report: https://www.marketdataforecast.com/market-reports/global-influenza-market-1704/

Influenza or flu is a transmittable respiratory disease which affect nose, throat, and lungs. Influenza viruses are basically of three types-Type A (H1N1, H2N2, and H5N1, etc.), Type B, and Type C. It can be either seasonal, pandemic, or zoonotic. Influenza can be fatal if goes unnoticed and is regarded as a major reason of morbidity and mortality, globally. Some of the symptoms of influenza are fever, cough, sore throat, runny or stuffy nose, fatigue, headache, and body ache. According to World Health Organization, the flu occurs annually infecting 5% to 10% adults and 20% to 30% children, worldwide. Approximately, 3 to 5 million people gets severely infected resulting in 250,000 – 500,000 deaths. Children below 2 years of age and elderly above 65 years of age are at high risk of developing chronic flu.

Download free sample report: https://www.marketdataforecast.com/market-reports/global-influenza-market-1704/request-sample

The growth of Influenza market is majorly driven by factors such as boost in Research & Development investment, rising public awareness, increase in healthcare expenditure, cost-effectiveness of immunization, introduction of new medicines, and increasing government initiatives for vaccination against influenza viruses. Additionally, a large section of population, especially in Asian and African countries are not immunized against influenza virus, thereby fueling the demand for the product in developing and under developed economies. The key restraints of the market are antigenic shift of influenza virus, complex regulatory framework, lack of cold storage facility, side-effects of the product (soreness, swelling, and redness), lack of advanced technology for early detection of new influenza virus, and remote areas with limited accessibility.

The global Influenza Market is segmented on the basis of Product Type and Consumer. Based on Product Type, the market is classified into vaccines and drugs. On the basis of Consumer, the market is classified into Children and Adults. Vaccines (Fluzone, Afluria, Fluvirin, Flublok, and others) commands major market share which is estimated to be more than 80% and is anticipated to be fastest growing segment during forecast period.

Inquire before buying: https://www.marketdataforecast.com/market-reports/global-influenza-market-1704/inquire

The market has also been geographically segmented into North America, Europe, Asia-Pacific and the Middle-East and Africa. North America is expected to command the major market share of 50% in 2016.

The major companies dominating the global Influenza Market are Sanofi-Pasteur (U.S.), AstraZeneca (United Kingdom), F. Hoffmann-La Roche (Switzerland), Novartis (Switzerland), GlaxoSmithKline (U.K.), Pfizer Inc. (U.S.), Merck & Co. (U.S.), Abbott Laboratories (U.S.), Mitsubishi Tanabe Pharma Corporation (Japan), CSL Limited (Australia).

Market Segmentation                                              

Product Type                             

Introduction           

Vaccines   

Drugs         

Y-o-Y Growth Analysis, By Product              

Market Attractiveness Analysis, By Product            

Market Share Analysis, By Product              

Type                              

Introduction           

Safety Biomarkers

Efficacy Biomarkers             

Validation Biomarkers        

Y-o-Y Growth Analysis, By Type    

Market Attractiveness Analysis, By Type  

Market Share Analysis, By Type    

Application                 

Introduction           

Diagnostics Development 

Drug Discovery and Development

Personalised Medicine      

Disease Risk Assessment  

Other Applications               

Y-o-Y Growth Analysis, By Application        

Market Attractiveness Analysis, By Application      

Market Share Analysis, By Application       

Disease Indications                 

Introduction           

Cancer      

CardiovascularDisorders    

Neurological Disorders       

Immunological Disorders  

Other Diseases      

Y-o-Y Growth Analysis, By Disease Indications        

Market Attractiveness Analysis, By Disease Indications 

Market Share Analysis, By Disease Indications 

The scope of the report:

Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped

Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail

Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics

Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis

Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development

A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment

Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies

An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis, and main conclusions

Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

About Market Data Forecast:

Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialties with competitive pricing options. For more info kindly visit, www.marketdataforecast.com

Contact:

Abhishek Shukla

Sales Manager (International Business Development)

Market Data Forecast

Direct Line: +1-888-702-9626

Mobile: +91 998 555 0206

Mail: abhishek@marketdataforecast.com

Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/

View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases